Novartis has announced a partnership with Qualcomm Life, a subsidiary of Qualcomm, to develop a connected version of its inhaler, Breezhaler, for people who have COPD. Specifically, Qualcomm Life will ...
ZURICH (Reuters) - A Novartis lung drug met its main goals in three late-stage studies in patients with chronic obstructive pulmonary disease (COPD), often known as smokers' cough, the Swiss drugmaker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback